Yahoo
    XETRA - Delayed Quote EUR

    BioNTech SE (22UA.DE)

    78.15 -0.05 (-0.06%)
    At close: November 6 at 5:35:36 PM GMT+1
    Loading Chart for 22UA.DE
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Moderna Climbs 5% as Surprise Profit and Raised Outlook Beat Forecasts; Pfizer Dips, BioNTech Edges Higher

    Moderna Climbs 5% as Surprise Profit and Raised Outlook Beat Forecasts; Pfizer Dips, BioNTech Edges Higher
    24/7 Wall St. 1d ago
    BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo

    BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo
    Simply Wall St. 3d ago
    BioNTech SE (BNTX) (Q3 2026) Earnings Call Highlights: Oncology Pipeline Momentum Builds as ...

    BioNTech SE (BNTX) (Q3 2026) Earnings Call Highlights: Oncology Pipeline Momentum Builds as ...
    GuruFocus.com 3d ago
    Pfizer CEO Says Covid Is ‘Irrelevant.’ He’s Betting on Cancer and Weight-Loss Drugs.

    Pfizer CEO Says Covid Is ‘Irrelevant.’ He’s Betting on Cancer and Weight-Loss Drugs.
    Barrons.com 3d ago
    Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial

    Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial
    24/7 Wall St. 4d ago
    BioNTech Q3 Earnings Call Highlights

    BioNTech Q3 Earnings Call Highlights
    MarketBeat 4d ago
    PFE Beats Q3 Earnings & Sales Estimates, Raises 2026 Guidance

    PFE Beats Q3 Earnings & Sales Estimates, Raises 2026 Guidance
    Zacks 4d ago
    BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update

    BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update
    GlobeNewswire 4d ago
    BMY Q3 Earnings Tops Estimates, Higher Charges Weigh on Outlook

    BMY Q3 Earnings Tops Estimates, Higher Charges Weigh on Outlook
    Zacks 9d ago
    BioNTech (BNTX) Phase 3 Breast Cancer Win Comes With A Lung Safety Warning

    BioNTech (BNTX) Phase 3 Breast Cancer Win Comes With A Lung Safety Warning
    Simply Wall St. 10d ago
    Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher

    Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
    24/7 Wall St. 10d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: